Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Some quick thoughts:

1) this is a first deal for an undeveloped drug (UP/UPS) with only a human proof of concept Phase 2 trial. The licensee is responsible for all development costs.

2) there is still all other gastrointestinal Brilacidin drugs as well as the most lucrative OM.

3) the next licenses will be far better due to the indications at that point being more advanced clinically.

4) IPIX is still working on improved B-OM plus time-release capsules for upper and lower GI. Once those are done, more licenses and advanced phase testing.

This is only the beginning, though I had hoped for a little better first terms.